<DOC>
	<DOCNO>NCT01407601</DOCNO>
	<brief_summary>Vascular calcification ( VC ) predictor cardiovascular morbidity mortality . Hemodialysis ( HD ) patient suffer severe vascular calcification . Matrix Gla protein ( MGP ) central calcification inhibitor arterial wall activity depend vitamin K-dependent Î³-glutamate carboxylation . Noncarboxylated MGP , form result vitamin K deficiency , associate cardiovascular disease . Recent study point towards poor vitamin K status HD patient . We therefore aim investigate whether daily vitamin K2 ( MK-7 ) supplementation improve bioactivity vitamin K-dependent protein HD patient assess circulate dephospho-noncarboxylated MGP ( dp-ucMGP ) , noncarboxylated osteocalcin ( ucOC ) noncarboxylated prothrombin ( ucFII ; PIVKA-II ) .</brief_summary>
	<brief_title>Vitamin K2 Supplementation Activate Matrix Gla Protein ( MGP ) Endogenous Inhibitor Vascular Calcification Hemodialysis Patients</brief_title>
	<detailed_description />
	<mesh_term>Calcinosis</mesh_term>
	<mesh_term>Vascular Calcification</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin K</mesh_term>
	<mesh_term>Vitamin K 2</mesh_term>
	<mesh_term>Vitamin MK 7</mesh_term>
	<criteria>&gt; 18 year age minimum 3 month hemodialysis write consent chronic acute bowel disease soy bean allergy active Vitamin K Supplementation oral anticoagulation vitamin K Antagonists ( coumarins ) systemic therapy use steroid positive history thrombosis embolism pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>vitamin K</keyword>
	<keyword>MK-7</keyword>
	<keyword>Hemodialysis</keyword>
	<keyword>vascular calcification</keyword>
	<keyword>Matrix Gla protein</keyword>
	<keyword>Osteocalcin</keyword>
</DOC>